Virginia Chapter: Advancing Personalized Cancer Immunotherapies: Navigating Challenges, Regulations,

When:  Jan 14, 2026 from 12:00 PM to 01:00 PM (ET)
Associated with  ACRP Virginia Chapter

Virginia Chapter: Advancing Personalized Cancer Immunotherapies: Navigating Challenges, Regulations, and Strategies in Clinical Trial Design

 
Event Description:
Vaccines have proven effective in preventing diseases caused by viruses and bacteria. Since the first vaccine was developed more than 200 years ago, they have prevented some of the twentieth century’s deadliest diseases and have helped save hundreds of millions of lives globally.
 
Doctors can now identify targets on patients’ tumors that can help distinguish cancer cells from their normal cells. Sometimes these targets are normal proteins that are produced at abnormally high levels by cancer cells. Additionally, virus-derived proteins expressed by virus-infected cancer cells offer another promising source of markers that can be targeted through vaccines.
 
Join us to learn more about personalized therapies and their clinical trials. 
 
Speakers:
Joann Peters, MPH
 
Joann Peters is the Chief Operating Officer at Geneos Therapeutics, a Philadelphia based Biotech company specializing in DNA personalized cancer vaccines. At Geneos Joan is responsible for the daily operations of the business, leading efforts in scaling manufacturing and operational capacity and oversight of clinical operations. Prior to Geneos she had a distinguished 19-year career in the Contract Research Organization (CRO) industry, where she supported company growth strategies and led oncology-focused study teams. She held senior roles at PRA, Chiltern, INC and Linical. Joann received her Bachelors of Science degree from Iowa State University in Dietetics/ Food and Nutrition and holds a Masters of Health Care Administration from Webster University. 
 
Learning Objectives:
  1. Review of the therapeutic cancer vaccine landscape
  2. To explore the unique challenges and considerations when designing and conducting clinical trials for personalized therapies.
  3. To identify regulatory, ethical, and logistical factors influencing personalized medicine clinical trials.
  4. To discuss strategies for optimizing trial design and patient selection in personalized medicine research. 
 
Registration Information:
Click here to register before 1/13/26. Each attendee is required to have their own registration – only one registration per transaction.
 
  • Chapter Member: $0
  • ACRP Member: $15
  • Non-Member: $30
 
After registering, please visit the event's community page to find the login information or any additional event updates, and to communicate with the event organizer.
 
The educational portion of this event may be self-reported as 1 point toward an attendee’s Maintenance of Certification. These points are subject to review and acceptance by the Academy of Clinical Research Professionals in accordance with the criteria established. Attendees should keep a record of event participation in case they are randomly selected to participate in the maintenance verification process. The Chapter can provide a certificate of attendance upon request.

Location

Dial-in Instructions: